查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552614

奈米胶囊市场规模、份额、趋势分析报告：按应用、治疗领域、地区、细分市场预测，2024-2030

Nanocapsules Market Size, Share & Trends Analysis Report By Application (Healthcare, Food & Nutraceuticals, Cosmetics), By Therapeutic Area (Oncology, Pain Management, Endocrinology), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

奈米胶囊市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，预计到2030年全球奈米胶囊市场规模将达48.9亿美元。

预计2024年至2030年复合年增长率为5.4%。奈米胶囊透过标靶递送来递送生物活性分子，并在医疗保健、基因工程、食品科学和农业、化妆品、农业化学品和清洁产品等各个行业中得到应用。这些产品在各个行业的广泛使用为新的和改进的治疗方法和解决方案的开发和商业化带来了丰厚的机会。

奈米胶囊的生命科学应用依赖于其实现奈米药物载体受控且有效释放到目标区域的能力。奈米胶囊因其高效的药物靶向性而在医疗保健领域越来越受欢迎。奈米胶囊具有分散稳定性和快速的生理反应，其自燃和氧化特性使其越来越被接受为诊断和治疗医学疾病的有效药物。人们发现奈米技术在医学中的应用具有重要的治疗益处，特别是在肿瘤学中，从而导致了一个新领域的出现，即奈米肿瘤学，其中涉及奈米胶囊的化疗或诊断特性。

奈米技术的使用已扩展到各个科学领域，也应用于化妆品和农业。化妆品利用聚合物奈米颗粒（奈米球和奈米胶囊）进行有效的局部给药。同时，奈米技术被认为是现代农业最重要的工具之一，预计在不久的将来成为经济强劲成长的驱动力。然而，儘管奈米技术具有许多潜在好处，但目前在农业中的应用仍很薄弱，尚未实现巨大的市场潜力。然而，最近的研究表明，奈米胶囊及其各自的产品受到了人们的偏好，并且具有明显优势的奈米技术产品的日益商业化将推动消费者接受更精细的应用，这很有可能实现。

奈米胶囊市场报告亮点

  • 肿瘤学中的奈米胶​​囊旨在靶向肿瘤部位，然后根据不断变化的条件排放其内容物。
  • 奈米胶囊药物递送在疼痛管理和内分泌领域正在快速发展，具有很高的商业化潜力。
  • 医疗保健占据市场主导地位，到 2023 年将占据 63.3% 的份额，预计在预测期内将以最快的复合年增长率增长。
  • 北美和欧洲国家总合占60%的市场占有率。这是由于已开发国家增加了研发和投资活动的贡献，重点是开发新的、高效的改进治疗方法，包括使用奈米胶囊。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章奈米胶囊市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 奈米胶囊市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 奈米胶囊市场：依应用估算与趋势分析

  • 细分仪表板
  • 奈米胶囊市场：2023 年和 2030 年应用变化分析
  • 卫生保健
  • 食品/食品补充品
  • 化妆品
  • 其他的

第五章奈米胶囊市场：按治疗领域估计和趋势分析

  • 细分仪表板
  • 奈米胶囊市场：2023 年和 2030 年治疗领域变化分析
  • 肿瘤学
  • 疼痛管理
  • 内分泌学
  • 其他的

第六章奈米胶囊市场：区域估计和趋势分析

  • 2023 年及 2030 年奈米胶囊市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • BioDelivery Sciences
    • Camurus
    • Carlina Technologies
    • Cerulean Pharma Inc.
    • Nano Green Sciences, Inc.
    • NanoNutra
    • NanoSphere Health Science
    • Eos Biosciences, Inc.
    • PolyMicrospheres
    • GAT Food Essentials
简介目录
Product Code: GVR-1-68038-748-3

Nanocapsules Market Growth & Trends:

The global nanocapsules market size is expected to reach a value of USD 4.89 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.4% from 2024 to 2030. Nanocapsules deliver bioactive molecules by targeted delivery and find application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions.

Nanocapsules' life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare is gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.

The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.

Nanocapsules Market Report Highlights:

  • Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon a change in conditions.
  • Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has a high probability of commercialization.
  • Healthcare dominated the market and accounted for a share of 63.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • North America and Europe accounted for a collective market share of 60%. this is attributed to the contribution of highly developed countries in increasing R&D and investing activities focusing on the development of novel and highly effective improved therapies involving the use of nanocapsule.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nanocapsules Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nanocapsules Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nanocapsules Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nanocapsules Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Healthcare
    • 4.3.1. Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Food & Nutraceuticals
    • 4.4.1. Food & Nutraceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cosmetics
    • 4.5.1. Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nanocapsules Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nanocapsules Market: Therapeutic Area Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain Management
    • 5.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nanocapsules Market: Regional Estimates & Trend Analysis

  • 6.1. Nanocapsules Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. BioDelivery Sciences
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Camurus
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Carlina Technologies
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Cerulean Pharma Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Nano Green Sciences, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. NanoNutra
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. NanoSphere Health Science
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Eos Biosciences, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. PolyMicrospheres
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. GAT Food Essentials
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives